Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
NVIDIA
NVDA
|
$1B |
| 2 |
Netflix
NFLX
|
$721M |
| 3 |
Apple
AAPL
|
$468M |
| 4 |
UnitedHealth
UNH
|
$422M |
| 5 |
GE Vernova
GEV
|
$376M |
Top Sells
| 1 |
Broadcom
AVGO
|
$673M |
| 2 |
Robinhood
HOOD
|
$481M |
| 3 |
Meta Platforms (Facebook)
META
|
$433M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
$402M |
| 5 |
Palantir
PLTR
|
$380M |
Sector Composition
| 1 | Technology | 19.67% |
| 2 | Healthcare | 15.34% |
| 3 | Consumer Discretionary | 12.38% |
| 4 | Financials | 11.51% |
| 5 | Industrials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3401
Mangoceuticals
MGRX
$23.3M
| $47.1K | ﹤0.01% |
+31,000
| New | +$47.1K |
|
|
GRO
3402
Brazil Potash Corp.
GRO
$74.8M
| $46.6K | ﹤0.01% |
+34,300
| New | +$46.6K |
|
3403
Milestone Scientific
MLSS
$48.5M
| $46.6K | ﹤0.01% |
73,197
-4,559
| -6% | -$2.9K |
|
3404
CASI Pharmaceuticals
CASI
$36.3M
| $46.3K | ﹤0.01% |
39,200
+300
| +0.8% | +$354 |
|
3405
Verrica Pharmaceuticals
VRCA
$48.3M
| $46.2K | ﹤0.01% |
+8,720
| New | +$46.2K |
|
3406
Flora Growth
FLGC
$13M
| $46.2K | ﹤0.01% |
2,041
-62
| -3% | -$1.4K |
|
3407
Nexalin Technology
NXL
$14.6M
| $45.8K | ﹤0.01% |
+46,344
| New | +$45.8K |
|
3408
Acurx Pharmaceuticals
ACXP
$6.47M
| $44.8K | ﹤0.01% |
4,389
+3,059
| +230% | +$31.3K |
|
3409
Enveric Biosciences
ENVB
$2.95M
| $44.8K | ﹤0.01% |
+37,012
| New | +$44.8K |
|
3410
Nephros
NEPH
$40.6M
| $44.6K | ﹤0.01% |
+10,900
| New | +$44.6K |
|
3411
Wetouch Technology
WETH
$13.2M
| $44.1K | ﹤0.01% |
46,400
+8,600
| +23% | +$8.17K |
|
3412
TOP Financial Group
TOP
$42.6M
| $43.6K | ﹤0.01% |
35,600
+5,700
| +19% | +$6.98K |
|
3413
Nuvation Bio
NUVB
$1.33B
| $43.1K | ﹤0.01% |
22,100
-422,000
| -95% | -$823K |
|
|
HYFT
3414
MindWalk Holdings Corp. Common Stock
HYFT
$89.5M
| $42.9K | ﹤0.01% |
40,480
+11,080
| +38% | +$11.7K |
|
|
MOGO
3415
Mogo
MOGO
$43.5M
| $42.2K | ﹤0.01% |
33,500
-22,379
| -40% | -$28.2K |
|
3416
SunCar Technology Group
SDA
$271M
| $42.1K | ﹤0.01% |
+16,500
| New | +$42.1K |
|
3417
enGene Holdings
ENGN
$265M
| $41.5K | ﹤0.01% |
+11,400
| New | +$41.5K |
|
|
BEDU
3418
Bright Scholar Education Holdings
BEDU
$50.5M
| $41.1K | ﹤0.01% |
23,225
-200
| -0.9% | -$354 |
|
|
GXAI
3419
Gaxos.ai
GXAI
$11.1M
| $39.4K | ﹤0.01% |
+27,963
| New | +$39.4K |
|
3420
BranchOut Food
BOF
$26.5M
| $38.1K | ﹤0.01% |
15,683
-19,917
| -56% | -$48.4K |
|
3421
Dolphin Entertainment
DLPN
$14.1M
| $38.1K | ﹤0.01% |
33,100
+2,100
| +7% | +$2.42K |
|
3422
Tigo Energy
TYGO
$98.6M
| $37.9K | ﹤0.01% |
+29,712
| New | +$37.9K |
|
|
UBX
3423
DELISTED
Unity Biotechnology
UBX
| $37.8K | ﹤0.01% |
98,311
+4,100
| +4% | +$1.58K |
|
3424
Tandy Leather Factory
TLF
$24.8M
| $37.4K | ﹤0.01% |
12,100
-5,500
| -31% | -$17K |
|
|
TRIB
3425
Trinity Biotech
TRIB
$4.32M
| $37K | ﹤0.01% |
56,965
-19,700
| -26% | -$12.8K |
|